What Medication Can Cause Gastrointestinal Bleeding?

NSAIDs like ibuprofen and aspirin are the most common medications that cause gastrointestinal bleeding, but they’re far from the only ones. Blood thinners, antidepressants, corticosteroids, and even some osteoporosis drugs can all damage the digestive tract or impair your body’s ability to stop bleeding once it starts. The risk depends on the specific drug, the dose, and whether you’re taking more than one of these medications at the same time.

NSAIDs: The Most Common Cause

Nonsteroidal anti-inflammatory drugs, including ibuprofen, naproxen, and aspirin, are responsible for more cases of drug-induced GI bleeding than any other medication class. They work by blocking enzymes called COX-1 and COX-2, which produce protective compounds in the stomach lining. When both enzymes are suppressed simultaneously, the stomach loses its defenses on multiple fronts: blood flow to the lining drops, acid secretion increases, and the body’s ability to repair small wounds slows down.

The damage isn’t just chemical. NSAIDs also have a direct toxic effect on the cells lining the stomach and intestines. Reduced blood flow to the stomach wall happens because blocking COX-1 triggers the release of a powerful blood vessel constrictor, especially when stomach acid is present. Meanwhile, blocking COX-2 impairs the healing of any ulcers that form. This combination of increased acid, weakened defenses, and slower repair is what makes NSAIDs so damaging to the gut.

Aspirin deserves special attention. The U.S. Preventive Services Task Force now recommends against starting daily aspirin for heart disease prevention in adults 60 and older, largely because the bleeding risk outweighs the cardiovascular benefit at that age. For adults 40 to 59 with elevated heart disease risk, the decision is individual, and data suggest considering stopping aspirin around age 75. Both cardiovascular risk and bleeding risk climb with age, but the bleeding risk eventually wins out.

Blood Thinners and Anticoagulants

Anticoagulants prevent blood clots, which is exactly why they also make bleeding harder to stop. The newer direct oral anticoagulants (DOACs) have largely replaced warfarin for conditions like atrial fibrillation, but their GI bleeding profiles vary dramatically from one drug to another.

Rivaroxaban carries the highest GI bleeding risk among DOACs. In the pivotal stroke prevention trial, rivaroxaban at its standard 20 mg dose had a 66% higher rate of major GI bleeding compared to warfarin. In real-world studies of over 50,000 patients, rivaroxaban caused GI bleeding at a rate of 10.6 per 100 patient-years, compared to 7.2 for apixaban. Dabigatran at its higher dose (150 mg twice daily) also showed a 50% increased risk of major GI bleeding versus warfarin.

Apixaban consistently comes out as the safest option for the gut. Multiple studies show it carries a GI bleeding risk similar to or lower than warfarin, and roughly 40% lower than rivaroxaban. If you’re on an anticoagulant and have concerns about GI bleeding, this difference between specific drugs is worth discussing with whoever prescribes your medication.

Antiplatelet Drugs and Dual Therapy

Antiplatelet medications like clopidogrel work differently from anticoagulants but also increase bleeding risk. When combined with aspirin, a regimen called dual antiplatelet therapy (DAPT), the risk compounds. In the CHARISMA trial, which followed over 15,000 patients for a median of 28 months, 3.1% experienced bleeding complications. Gastrointestinal bleeding was the single most common type, outnumbering both intracranial bleeds and surgical bleeding. Moderate bleeding occurred in 2.1% of patients on dual therapy versus 1.3% on aspirin alone.

Dual antiplatelet therapy is typically prescribed after heart stents or acute coronary events, so stopping it prematurely carries its own serious risks. The key is knowing that GI bleeding is the primary bleeding complication so you can recognize it early.

Antidepressants (SSRIs)

Selective serotonin reuptake inhibitors, the most widely prescribed class of antidepressants, increase GI bleeding risk through a mechanism most people wouldn’t expect. Platelets, the blood cells responsible for forming clots, store about 99% of the serotonin in your bloodstream. They release serotonin at injury sites to help clots form. SSRIs block serotonin from being reabsorbed into platelets, depleting their serotonin stores by more than 80%. With less serotonin available, platelets can’t aggregate as effectively, and bleeding takes longer to stop.

This effect is significant on its own but becomes especially concerning when SSRIs are combined with NSAIDs or aspirin. The SSRI weakens clotting ability while the NSAID damages the stomach lining, creating a situation where bleeding is more likely to start and harder to stop. If you take an SSRI alongside a regular NSAID or aspirin, your combined risk is meaningfully higher than either drug alone.

Corticosteroids

Oral corticosteroids like prednisone have long been suspected of causing GI bleeding, and a systematic review published in BMJ Open confirmed the risk is real even without other contributing factors. When researchers excluded studies where patients also took NSAIDs, had prior ulcers, or used stomach-protecting medications, corticosteroids still carried a 42 to 47% increased risk of GI bleeding compared to non-use.

The exact mechanism isn’t fully understood, but corticosteroids appear to impair tissue repair and delay wound healing throughout the body, including the digestive tract. This means small injuries to the stomach or intestinal lining that would normally heal quickly can instead worsen and bleed. The risk is most relevant for people on longer courses of oral steroids rather than short bursts.

Osteoporosis Medications

Oral bisphosphonates, commonly prescribed for osteoporosis, can irritate and injure the esophagus through direct contact between the pill and the lining of the upper digestive tract. Each time you swallow a bisphosphonate tablet, the pill itself can cause local inflammation where it touches the esophagus. Over time, this repeated contact can lead to esophageal ulcers and, in some cases, a precancerous condition called Barrett’s esophagus.

This is why bisphosphonates come with specific instructions: take them with a full glass of water, remain upright for at least 30 minutes afterward, and don’t lie down until after eating. These steps minimize the time the pill spends in contact with your esophagus. Researchers have found that patients starting bisphosphonates are more likely to need prescription antacids shortly after, suggesting that early irritation is common enough for clinicians to treat it proactively.

Recognizing GI Bleeding

If you take any of these medications, knowing what GI bleeding looks like can help you catch it before it becomes dangerous. The signs depend on where in the digestive tract the bleeding originates.

  • Black, tarry stools (melena): This indicates bleeding from the stomach or upper intestine. The blood turns black as it’s digested. These stools are distinctly jet black and sticky, not just dark brown.
  • Vomiting blood or coffee-ground material: Red blood in vomit suggests active upper GI bleeding. Brown, grainy material that looks like coffee grounds means blood has been partially broken down by stomach acid.
  • Bright red blood in or on stools: This typically points to bleeding lower in the digestive tract, such as the colon or rectum.

Less obvious signs include unexplained fatigue, lightheadedness, or gradually worsening anemia, which can indicate slow, chronic bleeding that doesn’t produce visible changes in your stool.

Reducing Your Risk

Proton pump inhibitors (PPIs) like omeprazole are the main tool for protecting the stomach when you need to stay on a high-risk medication. PPIs are recommended for anyone taking NSAIDs or aspirin who also has risk factors for GI bleeding, such as older age, a history of ulcers, or use of multiple blood-affecting drugs at the same time.

Not everyone on these medications needs a PPI, though. Identifying patients at low risk who won’t benefit from routine stomach protection is just as important as treating high-risk patients, since PPIs carry their own side effects with long-term use. The practical takeaway: if you’re on one of the medications above and you have additional risk factors (age over 65, history of stomach ulcers, taking more than one drug from this list), stomach protection is worth asking about. If you’re young, on a single medication, and have no GI history, you likely don’t need it.

The single biggest risk multiplier is combining medications from different categories. An NSAID with an anticoagulant, an SSRI with aspirin, or a corticosteroid with an NSAID each creates a compounding effect where one drug damages the lining while another impairs clotting. When possible, using the lowest effective dose for the shortest necessary time reduces exposure across all these drug classes.